NCT02006147: A trial that was reported late by Taiwan Liposome Company
This trial has reported, although it was 132 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02006147 |
|---|---|
| Title | Phase I/II Trial of TLC399 (ProDex) in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 30, 2014 |
| Completion date | July 15, 2020 |
| Required reporting date | July 15, 2021, midnight |
| Actual reporting date | Nov. 24, 2021 |
| Date last checked at ClinicalTrials.gov | May 15, 2026 |
| Days late | 132 |